Probiotics Strains for Infant Colic
Colic
About this trial
This is an interventional prevention trial for Colic focused on measuring infant colic, probiotic
Eligibility Criteria
Inclusion Criteria: Age 20 days ± 3 days. Informed consent form signed by parents Both gender Availability to complete scales daily and answer phone calls and/or text messages. Exclusion Criteria: Birth weight <2500 g; current intake of antibiotics, prebiotics, or probiotics by the baby or mother; Children with known moderate or severe disease of any system (neural, skeletal, muscular, cutaneous, gastrointestinal, respiratory, genital, urinary, immune), parental difficulty in understanding study requirements as judged by physician.
Sites / Locations
- Monique MichelsRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Placebo Comparator
Experimental
Experimental
Placebo
Limosilactobacillus reuteri CCT 7862
Bifidobacterium lactis CCT 7858 + Lactobacillus rhamnosus CCT 7863
product vehicle (sunflower oil)
Limosilactobacillus reuteri CCT 7862 - 1 x 10e9 UFC/ daY.
Blend: Bifidobacterium lactis CCT 7858 + Lactobacillus rhamnosus CCT 7863 - 1 x 10e9 UFC/ day.